chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 47 month old female with no pertinent medical history and no allergies who on 02 May 2003 was vaccinated subcutaneously with a first dose of Varivax (lot # 638367/0198M). Concomitant vaccination included a first dose of MMR II (lot # 644646/1230M). There was no illness at the time of vaccination.  On 10 Apr 2006 the patient developed 20-30 varicella lesions (previously reported as 10 itchy varicella lesions and no other symptoms). Medical attention was sought. Treatment included Benadryl and Aveeno. There was no labs or diagnostic studies performed. At the time of this report the patient recovered. No product quality complaint was involved. Additional information is not expected.
Age: 1.3
Sex: M
Vaccine: VARCEL
Symptoms: Impetigo, Pruritus, Rash vesicular, Rhinorrhoea, Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 32-month-old white male with no known allergies and no pertinent medical history who on 19-NOV-2004 was vaccinated SC with the first dose of Varivax (Lot #646819/1065N). There was no concomitant therapy or illness at the time of vaccination. The RN reported that on 10-APR-2006, the patient was seen by his physician with a runny nose, vesicular lesions with red base on his abdomen, axillary area, behind his ear and on his back. He had no fever. He complained of itching. There were approximately 25 lesions. There were no laboratory tests performed. A diagnosis of chickenpox with impetigo was made. The patient was treated with Benadryl and Aveeno Bath. The patient's chickenpox and impetigo subsequently resolved. Additional information is not expected.
Age: 1.5
Sex: M
Vaccine: MMRV, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a company representative concerning her 18 month old nephew with no pertinent medical history or allergies who on 07 Apr 2006 was vaccinated with a dose of Varivax. Several hours after vaccination, the patient developed a rash. It was reported that it was unknown whether the vaccine was Varivax or Proquad. The patient was seen by a pediatrician. The patient's symptoms resolved with the use of calamine lotion. The outcome is recovered. No product quality complaint was involved. Additional information is not expected.
Age: 1.5
Sex: U
Vaccine: VARCEL
Symptoms: Vaccination failure
Clinical narrative: Information has been received from a health professional concerning a 7 year old patient who on 07-SEP-2000 was vaccinated with a dose of Varivax. It was reported that the patient experienced vaccine failure. The patient was evaluated by a medical doctor. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash, Skin lesion, Varicella
Clinical narrative: Information has been received from a certified medical assistant concerning a 9 year old female with no allergies or medical history who on 28 Apr 1998 was vaccinated in the right anterior thigh with a dose of Varivax (lot# 624655/1320E). There was no concomitant medication. On 13 Mar 2006, the patient was diagnosed chickenpox. The patient was seen by the physician and had a fever of 102.1 and a rash on her face, torso, arms, legs. She had one lesions on her hypopharynx. The physician placed her on acyclovir. No diagnostic laboratory tests were performed. Subsequently, the patient recovered from chickenpox and was described as fine. A product quality complaint was not involved. Chickenpox was determined to be an other important medical event by the reporter. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a certified medical assistant concerning a 9 year old female with no allergies or medical history who on 28 Apr 1998 was vaccinated in the right anterior thigh with a dose of Varivax (lot# 624655/1320E). There was no concomitant medication. On 13 Mar 2006, the patient was diagnosed chickenpox. The patient was seen by the physician and had a fever of 102.1 and a rash on her face, torso, arms, legs. She had one lesions on her hypopharynx. The physician placed her on acyclovir. No diagnostic laboratory tests were performed. Subsequently, the patient recovered from chickenpox and was described as fine. A product quality complaint was not involved. Chickenpox was determined to be an other important medical event by the reporter. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning her approximately 6-year-old son who in 2001 was vaccinated with a dose of Varivax. Subsequently, on an unspecified date in 2001, the patient experienced mild chickenpox. Unspecified medical attention was sought. It was reported that the patient recovered. No product quality complaint was involved. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Information has been received from a health professional concerning a 4 year old female with no medical history or allergies who on 13-SEP- 2002 was vaccinated with Varivax (lot# 642680/0379M). There was no concomitant medication. On 01-MAR-2006 the patient experienced red, itchy spots that were treated with Aveeno bath. Medical attention was sought but no labs were done. The patient recovered. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 6 year old male with no known medical history or allergies who on 10-JUL-2001 was vaccinated with a SC dose of Varivax (lot # 638818/0499L). There was no concomitant medication. On 07-APR-2006 the patient developed chickenpox spots. Unspecified medical attention was sought. He was treated with Benadryl. No laboratory diagnostic tests were performed. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a certified medical assistant concerning a 13-year-old female with no pertinent medical history and no drug reactions/allergies who on 12-MAR-1996 was vaccinated with a dose of Varivax. There was no concomitant medication. On 29-MAR-2006 the patient developed 100-150 lesions and was treated with acyclovir. There were no lab diagnostic studies performed. The outcome was reported as recovered. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Exposure to communicable disease, Rash
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old female with vesicoureteric reflux and no drug reactions/allergies who on 19-OCT-1998 was vaccinated with a dose of Varivax. There was no illness at the time of vaccination. There was no concomitant medication. On 06-APR-2006 the patient experienced a rash on her right neck, extremities, and body. It was noted that the rash started on her neck and spread to her extremities. Twenty to twenty-five vesicular lesions were noted.  She was seen in the office on 07-APR-2006 with no fever and less then 50 lesions (with some lesions crusted over). She was treated with Benadryl. It was noted that one and a half weeks prior to onset of symptoms, the patient was exposed to an aunt who had shingles. There were no lab diagnostic studies performed. The outcome was reported as recovering. There was no product quality complaint. Follow up information indicated that the patient recovered on 08-APR-2006. It was also noted that the patient was exposed to shingles 1.5 weeks prior to onset. No additional information is expected.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister
Clinical narrative: Information has been received from a licensed practical nurse (LPN) concerning an 11-year-old white male student who on 27-MAY-1999, at 5 years of age, was vaccinated SC with the first dose of Varivax. There was no concomitant therapy. The LPN reported that on 05-APR-2006, at 1500, the patient developed 50-75 vesicles on chest, back, legs, arms and face. Medical attention was not sought and no laboratory/diagnostic tests were performed. On 11-APR-2006 the patient recovered. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: VARCEL
Symptoms: Oral soft tissue disorder, Skin lesion
Clinical narrative: Information has been received from a certified medical assistant concerning a 9 year old male with no known drug allergies, ADH and bipolar disorder who on 03 Feb 1998 was vaccinated with a dose of Varivax. Concomitant therapy included Risperdal and "others" (therapy unspecified). On 05 Mar 2006 the patient developed lesion on his body and in his mouth. No lab or diagnostic studies were done. The patient was treated with comfort measures (not futher specified). Subsequently, the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a nurse practitioner (NP) concerning an adult female with three children, who underwent varicella titers prior to getting pregnant. The patient titers "kept coming back negative," therefore the patient received two doses of Varivax prior to each pregnancy (total of 6 doses "over many years"). Unspecified medical attention was sought. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Age: 1.5
Sex: M
Vaccine: DTAP, HIBV, MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old white male who on 07-JUL-1999 was vaccinated SC with a first dose of Varivax. Concomitant vaccination on the same day included a SC first dose of MMR II (lot # 631056/0532J), an IM fourth dose of Tripedia (lot # P0897AA) and an IM fourth dose of ACTHIB (lot # 7172AA). On 07-JUL-2005, the patient developed varicella disease. The patient recovered on 17-JUL-2005. Additional information is not expected.
Age: 1.3
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning a 5 year old male who on 21 Aug 2001 was vaccinated with a dose of Varivax (lot # 637667/1606K). Concomitant vaccination included a dose of MMR II. On 04 Apr 2006 it was reported that "within the last 1-2 weeks" the patient experienced breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. Followup information from the nurse indicated that all the information on the varicella vaccine and the chicken pox was submitted. No further information is available.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a licensed practical nurse concerning a 5 year old female who on 18-OCT-2001 was vaccinated with a dose of Varivax (lot # 637667/1606K). On 27-MAR-2006 the patient was diagnosed with chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. Follow-up information from the nurse indicated that all the information on the varicella vaccine and the chickenpox was submitted. No further information is available.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old male who on 15-JUN-2005 was vaccinated SC in the left thigh with a first dose of Varivax (lot # 648052/1351N). There was no illness at the time of vaccination. ON 22-JUN-2005, the patient developed varicella disease and subsequently recovered on an unspecified date. Additional information is not expected.
Age: 1.1
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 43-month-old black female who on 01-MAY-2003 was vaccinated subcutaneously in the right thigh with a first dose of Varivax (lot# 641712/0423M). Concomitant therapy included a dose of MMR II. On 15-OCT-2005 the patient had an adverse experience. Unspecified medical attention was sought and it was noted that there was "confirmation (at an) office visit." Subsequently, the patient recovered from the adverse experience on an unspecified date. Additional information has been requested.
Age: 1.9
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old white male who on 16-NOV-1998 was vaccinated SC in the left thigh with a first dose of Varivax (lot # 621060/1363D). There was no illness at the time of vaccination. On 06-FEB-2006, the patient developed acquired varicella signs and symptoms. The patient had an office visit only. No diagnostic laboratory tests were performed. The patient recovered on 20-FEB-2006. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Body temperature, Rash, Skin lesion
Clinical narrative: Information has been received from a health professional concerning a 5 year old male who on 26-FEB-2003 was vaccinated with a first subcutaneous dose in the right arm of Varivax (Lot # 643588/0804M). Concomitant vaccine administered on the same day included a first dose in the left deltoid of Havrix (Lot# VHA709A2). On 05-APR-2006 the patient was diagnosed with a rash with less than 150 lesions that began on 03-APR-2006. There was no fever, no reliable prior history of chickenpox, and no complications. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: HEP, MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old female (41 inches, 36.3 pounds) who on 14-FEB-2003 was vaccinated subcutaneous (left arm) with Varivax (lot # 643588/0804M). Concomitant therapy that day included MMR II (lot# 642703/0629M) administered SC and Recombivax (lot# 643684/0707M) administered IM. On 31-MAR-2006 the patient developed a chickenpox (varicella) rash consisting of less than 50 lesions. She did not have a fever, and she had no reliable prior history of chickenpox. She was diagnosed with chickenpox on 03-APR-2006 by the registered nurse at her preschool. There were no relevant diagnostic or laboratory tests performed. The patient's outcome was not reported. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister
Clinical narrative: Information has been received from a LPN concerning a 6 year old male with no allergies or medical history who on 23 Jun 2000 was vaccinated with a 0.5ml dose of Varivax (lot # 634506/1770J). There was no concomitant medication. ON 12 Apr 2006 the patient presented with about 20 vesicular lesions spread over his scalp, trunk arms and legs. No other symptoms were noted. No labs were done. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Rash pruritic, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 13 month old male who on approximately 27 Mar 2006 was vaccinated with a dose of Varivax (lot#652663/1032R). On 10 Apr 2006, approximately 2 weeks post vaccination, the patient developed chicken pox with a head to toe rash. The rash was described as itchy and uncomfortable. He was not hospitalized but treated with supportive measures by the physician. The patient's current status was unknown. There was no product quality complaint involved. Additional information has been requested.
Age: 28.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Information has been received from a nurse practitioner concerning a 28 year old female who on 10 Apr 2006 at 9:30 am was vaccinated SC with a 0.5 mL first dose of Varivax (lot# 647538/0784R). There was no illness at the time of vaccination. ON 10 Apr 2006, within 24 hours after vaccination, the patient developed injection site soreness, erythema about inch in diameter, 3 inch induration, "local heat" and pruritis. The patient was reported as recovering. There was no product quality complaint involved. Additional information is not expected.
Age: 1.08
Sex: M
Vaccine: VARCEL
Symptoms: Gait disturbance
Clinical narrative: Information has been received from a physician concerning a 13 month old male who on 03-APR-2006 was vaccinated with a dose of Varivax. On 04-APR-2006 the patient was progressively experiencing difficulty walking, and by 7:30 pm that evening the patient was not able to walk. The patient was evaluated in an emergency room, but it was not specified if the patient was admitted to the hospital. By 05-APR-2006 the patient was improving, and was recovered by 07-APR-2006. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.4
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from an office manager concerning a 10 year old male with an allergy to antibiotics who on 31-JAN-1997 was vaccinated with Varivax (lot # 620623/1353D). On 31-MAR-2006 the patient experienced chickenpox. No labs were done. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Blood test
Clinical narrative: Information has been received from an approximately 35 year old female with aspirin allergy and no pertinent medical history who in 2003 "three years ago" was vaccinated with two 0.51 ml doses of varicella virus vaccine live (Oka/Merck). Concomitant therapy included levothyroxine Na (Synthroid). The patient reported that she tested positive for immunity for varicella after vaccination, but a recent test in approximately 2006 showed she has no immunity. "Bloodwork" was done. Outcome was reported as not recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Skin lesion, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old white female who on 03-MAY-1996 (also reported as 13-OCT-2000) was vaccinated with a dose of Varivax (lot# not reported). On 04-APR-2006 the patient developed varicella infection with less than 50 lesions. The patient also had a fever. No treatment was given. Subsequently, the patient recovered. There was no product quality complaint involved. No additional information is expected.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash, Rash vesicular
Clinical narrative: Information has been received from a licensed practical nurse concerning a 9 year old female with no known medical history or allergies who on 08-FEB-2000 was vaccinated in the left arm with a 0.5 mL SC first dose of Varivax (lot # 631779/1354J). There was no illness at the time of vaccination. On 11-APR-2006 the patient went tot he office complaining of a fever and a rash on the neck and back that started on 10-APR-2006. It was reported that she developed a fever of 101 and about 80 vesicular lesions on her neck and trunk, also described as multiple varicella-like lesions on back and neck. Unspecified medical attention was sought. The patient recovered on 20-APR-2006. There was no product quality complaint involved. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 10 year old female who on 13-OCT-2000 (also reported as 03-MAY-1996) was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The RN reported that on 06-APR-2006 the patient broke out with a varicella infection characterized by less than 50 lesions. The patient was noted to be afebrile. Unspecified medical was sought and no treatment was given. At he the time of this report the patient was recovering. No additional information is available.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 5 year old female who on an unspecified date, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). In April 2006, the patient developed a mild breakthrough case of varicella. unspecified medical attention was sought. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Viral test negative
Clinical narrative: Information has been received from a physician concerning a 26-year-old female who "four years ago" in 2002 was vaccinated with a dose of Varivax. Subsequently, the patient had a titer test and it showed negative results. At an unknown time, another dose of Varivax was given. A booster dose was also given at an unknown time. The patient had a repeat titer taken and it still showed a negative titer. No specific dates were given regarding the vaccine doses. Unspecified medical attention was sought. No further information was available at the time of this report. Additional information has been requested.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Rash pruritic, Rash pustular
Clinical narrative: Information has been received from a licensed practical nurse (LPN) concerning a 7 year old black male with no pertinent medical history or allergies  who on 22-MAY1993 was vaccinated SC in the left arm with the first dose of varicella virus vaccine live (Oka/Merck) Lot #6266688/0650H). There was no illness at the time of the vaccination. There was no  concomitant therapy. The LPN reported that on 12-APR-2006, the patient developed an itchy rash of red raised spots and pustules on his face, neck,  back and arms. The patient presented to a walk-in facility. No laboratory/diagnostic tests were performed. On 16-APR-2006, the patient's rash resolved. Additional  information is  not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a health professional concerning a child who was vaccinated with Varivax at 15 months of age. On 14-APR-2006 it was reported that the patient "recently" experienced shingles. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from the nurse indicated that she was unable to recall an adverse experience for Varivax. No further information is available.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old white female with no known medical history or allergies who on 19-OCT-1999 was vaccinated with a first dose of Varivax (lot # "07265"). There was no illness at the time of vaccination. On 07-APR-2006 the patient developed a rash with less than 50 lesions. The patient was afebrile. The patient was seen in the office on 11-APR-2006. No laboratory diagnostic tests were performed. On 14-APR-2006 (previously reported as 11-APR-2006) the patient recovered. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old white female who on 12-FEB-1998 was vaccinated with a dose of Varivax. On 06-APR-2006 the patient developed chickenpox. She was diagnosed on 07-APR-2006. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information is not expected.
Age: 13.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 13 year old white female who may have been vaccinated with a dose of Varivax. The nurse had no record of vaccination. However, the patient's mother stated that the child had the vaccine. On 01-APR-2006 the patient was diagnosed with chickenpox which started on 31-MAR-2006. Unspecified medical attention was sought. There was no product quality complaint involved. No other information was available. Additional information is not expected.
Age: 1.2
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a medical center concerning a 7-year-old white male who on 31-JAN-2000 was vaccinated with a first dose of Varivax. ON 26-MAR-2006 the patient experienced chickenpox. Unspecified medical attention was sought. No outcome was reported. Additional information has been requested.
Age: 1.6
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a medical center concerning a 7 year old female who on 06-JUN-2000 was vaccinated with Varivax. On 14-MAR-2006 the patient experienced chickenpox. She was diagnosed on 15-MAR-2006. No additional information was provided. The patient's sibling (WAES 0604USA02514) had a similar experience after vaccination with Varivax. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a medical center concerning a 6 year old female who on 10-SPE-2001 was vaccinated with Varicella. On 21-MAR-2006 the patient experienced chicken pox. She was diagnosed on 23-MAR-2006. No additional information was provided. The patient's sibling (WAES 0604USA02512) had a similar experience after vaccination with Varivax. Follow-up information from the licensed practical nurse indicated that all information is available.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Cough, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male with no known medical history or allergies who on 24-SEP-1999 was vaccinated with a SC dose of Varivax (lot # "1074J"). There was no concomitant medication. There was no illness at the time of vaccination. On 13-APR-2006 the patient developed varicella with a rash on his body and a cough. Unspecified medical attention was sought and he was diagnosed on 14-APR-2006. No laboratory diagnostic tests were performed. He was treated with Benadryl and Sarna lotion. The patient's outcome was recovered. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Incorrect route of drug administration, Rash
Clinical narrative: Information has been received from a consumer concerning her daughter with no known medical history or allergies who in October 2005 was vaccinated IM in the gluteal muscle with a dose of Varivax. Concomitant vaccination included a dose of MMR II. Subsequently, the patient experienced spots on her stomach and behind the ears. Unspecified medical attention was sought. Subsequently the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: IPV, MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from physician concerning a 4 year old female with no medical history and no allergies who on 17-JAN-2003 was vaccinated SC with a 0.5ml dose of Varivax (lot "1326M"). Concomitant therapy included a dose of MMR II and a dose of poliovirus vaccine. There were no other concomitant medications. In November 2005, the patient experienced breakthrough. No labs were done. At the time of this report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Rash maculo-papular
Clinical narrative: Information has been received from a physician concerning a 12 month old male who on 06-APR-2006 was vaccinated with a dose of Varivax. On 16-APR-2006, the patient developed a fever and a maculopapular rash. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: DTP, HIBV, MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 9 year old male with no medical history or allergies who on 22-JUN-1998 was vaccinated with a 0.5 ml dose of Varivax. Concomitant therapy included MMR II, Hib conj vaccine (OMPC) (manufacturer unknown) and diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid. There were no other concomitant medications. In November 2005, the patient experienced breakthrough chickenpox. Unspecified medical attention was sought but no labs were done. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 0.3
Sex: F
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration, Varicella
Clinical narrative: Information has been received from a physician concerning a 3 year old female with no known medical history or allergies who on 23-APR-2004 was vaccinated with a 0.5 mL SC dose of Varivax (lot # 647087/0851N). There was no concomitant medication. In February 2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. No laboratory diagnostic tests were performed. At the time of the report the patient was recovering. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a female who in 1996 was vaccinated with a dose of Varivax. Subsequently, "now", on approximately 17-APR-2006, the patient experienced severe case of chickenpox. Unspecified medical attention was sought. No outcome was reported. No product quality complaint was involved. The R.N. also reported that the patient's brother had a severe case of chickenpox (WAES#0607USA01261). Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Pain
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated with a dose of Varivax. It was reported that the patient experienced slight stinging or a little pain. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Varicella
Clinical narrative: Information has been received from a physician's assistant (PA) concerning a 9-year-old female who was vaccinated SC with a 0.5 mL dose of Varivax. The PA reported that a few years after being vaccinated with Varivax, the patient developed breakthrough chickenpox. The PA also reported that in 2006, the patient developed shingles. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning an approximately 4 year old female who in approximately 2003, at one year of age, was vaccinated SC with a 0.5ml dose of Varivax. Subsequently the patient experienced shingles. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 9 year old white female, with no medical history and no allergies, who on 01-MAY-1998 was vaccinated with a first dose of Varivax. There were no adverse events following prior vaccination. On 10-APR-2006 that patient was diagnosed with chickenpox, over 30 vesicles. It was noted that the patient caught the chickenpox from her brother. The reporter was not sure if the patient recovered. There were no laboratory or diagnostic tests performed. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health care worker concerning a 6 year old female with no known medical history who on 30-AUG-2000 was vaccinated SC in the right thigh with a first dose of Varivax (lot # 634502/0538K). There was no illness at the time of vaccination. On 13-APR-2006 the patient developed chickenpox. No further information was provided. Additional information was received and indicated that on 13-APR-2006 the patient developed chickenpox and was seen for a doctor's visit. No laboratory tests were performed. Subsequently in April 2006 the patient made a full recovery. No further information is expected.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a person in a pediatric office concerning a 6-year-old white female with no pre-existing allergies, birth defects, or medical conditions who on 30-Aug-2000 was vaccinated with a first dose of Varivax (lot# 634502/0538K). There was no illness at the time of vaccination. The child was well. Subsequently, on 13-APR-2006, the patient developed chickenpox. No medical attention was sought. The outcome was reported as recovered in April 2006. There were no relevant diagnostic tests or laboratory data. No additional information is expected.
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Seroconversion test negative
Clinical narrative: Information has been received from a pharmacist concerning an adult female who was vaccinated, "awhile ago," with one dose of Varivax. It was reported that the patient failed to seroconvert. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning her son, a 6 year old male who at 12 months of age in approximately June 2000, was vaccinated with a dose of Varivax. In April 2006, the patient developed chickenpox with greater than 50 lesions. Unspecified medical attention was sought. The patient was recovering and was back at school with the crusted over lesions. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Injection site mass, Skin warm
Clinical narrative: Information has been received from a health professional concerning an adult female with an allergy to neosporin who on 03-APR-2006 (also reported as 04-APR-2006) was vaccinated with a dose of Varivax. On 17-APR-2006 the patient developed a bump at the injection site that was 3cmx3cm. By 20-APR-2006 the bump was 7cmx5cm. The bump was hot to the touch. The patient was treated with cold packs and Advil. At the time of this report the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse in a physician's office concerning a pediatric patient who may have been vaccinated with a dose of Varivax (lot # not reported). Subsequently the patient developed a mild case of chickenpox, 8-15 lesions. The patient's outcome was not reported. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning her son who was vaccinated with a dose of Varivax. The RN reported that her son subsequently developed breakthrough chickenpox. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information is not expected.
Age: 18.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a health professional concerning an 18 year old female, with no allergies, who on 17-MAR-2006 was vaccinated with a 0.5 ml subcutaneous dose of Varivax (Lot# 646670/0627R). "Two to three weeks later", in approximately April 2006, the patient broke out with 10 lesions on her scalp and head. She saw her private phyisican and was diagnosed with chickenpox. She was given an antiviral medication, unspecified. Subsequently, the patient recovered. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 6-year-old female child who on 19-MAY-2000 and 19-APR-2001 was vaccinated with a first (administered SC) and second doses of Varivax. On 07-JUL-2005, the patient developed Varivax. The outcome was reported as recovered. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a consumer concerning a child who was vaccinated with a dose of Varicella. The reporter indicated that her child attended a school where another child in the first or second grade was reported to have developed a case of break through chickenpox on approximately 21-APR-2006. It was unknown if medical attention was sought. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning an adult patient who was vaccinated with a dose of Varivax. Two weeks later the patient experienced varicella with more than 100 lesions. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster, Neoplasm, Nuclear magnetic resonance imaging
Clinical narrative: Information has been received from a physician concerning a child who was vaccinated with  Varivax. "Some time ago" the patient experienced shingles and was hospitalized. It was reported that the shingles lesions were located on the leg. It was also noted that, while hospitalized, the patient was going to undergo a MRI possibly to rule out a tumor in the hip area. Recovery status was unknown. There was no product quality complaint involved. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash generalised, Rash papular, Rash vesicular
Clinical narrative: Information has been received from a health professional concerning a 45 month old female who on 05-AUG-2003, at 6:30 pm, was vaccinated with a first 0.5 ml subcutaneous dose in the left thigh of Varicella (Lot# 643824/0870M). Concomitant vaccine administered at the same time included a first subcutaneous dose in right thigh of MMR II (Lot# 643953/0926M). On 21-APR-2006 the patient developed a vesicular rash of about 50-60 lesions. It was noted that the rash was found over the child's entire body. The patient was treated with over the counter Benadryl and calamine lotion. At the time of the report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided." Follow-up information from a health professional indicated that the patient was seen by a physician on 22-APR-2006 with one day of rash and fever beginning on 21-APR-2006, with 50-60 papular and vesicular lesions on her trunk, face, scalp, extremities, and pharyngeal mucosa. It was noted that the patient was exposed to Varicella 2-3 weeks prior. The patient was treated with calamine lotion, Benadryl, oral administration. No aspirin (A.S.A.) or ibuprofen was used. It was noted that the patient recovered. Additional information has been requested.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning her 4 year old son, with no medical history and no allergies, who, at one year of age, on 22-AUG-2002, was vaccinated with a first dose in the left arm of Varivax (Lot# 642995/0475M). "Now," on 22-APR-2006, at 8:00 am, the patient experienced mild, breakthrough chickenpox, with 10-30 lesions. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. The patient's sisters experienced varicella following vaccination with Varivax (WAES# 0603USA00757 and 0603USA02407). Additional information has been requested.
Age: 45.0
Sex: M
Vaccine: VARCEL
Symptoms: Headache, Incorrect route of drug administration, Pain, Rash maculo-papular, Rash papular
Clinical narrative: Information has been received from a physician's assistant (PA) concerning a 45-year-old male who on 12-APR-2006 was vaccinated intramuscularly with a 0.5 ml dose of Varivax (lot# 651280/0408R). There was no concomitant medication. On 22-APR-2006 the patient developed a macular papular rash, headache and achiness. It was also reported that the patient had 4-5 red papular lesions generally located on his body. Unspecified medical attention was sought. At the time of this report, it was noted that the patient's rash persisted. No product quality complaint was involved. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a physician concerning a 5-year-old male with a penicillin allergy and a history of neutropenia (on 08-JAN-2005), who on 27-JAN-2005 was vaccinated in the left arm with a dose of Varivax (lot# 649846/0767P). At the time of vaccination the patient was on acyclovir for treatment of neutropenia consistent with viral EBV. On 24-APR-2006 the patient experienced shingles in the T2 dermatome. The patient did not experience a fever. Unspecified medical attention was sought and the patient was entered in the VZV identification program on 27-APR-2006. The specimen was from a lesion and the result indicated that it was vaccine strain. It was noted that there was no history of chickenpox or recent exposure to chickenpox or herpes zoster. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with Varivax. "Some time ago" the patient experienced shingles. It was reported that the shingles lesions were located on the leg. Recovery status was unknown. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a child who, in the past, was vaccinated with Varivax. In approximately 2005, within the last year, the patient experienced a minor case of breakthrough chickenpox. Subsequently, the patient fully recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received, concerning a female patient who was vaccinated with a dose of Varivax twice as an adult and has not been able to develop immunity. No additional information was provided.
Age: 1.4
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a consumer concerning her 16 month old nephew with no pertinent medical history and no allergies, who "about two weeks ago" on approximately 03 Apr 2006 was vaccinated with a dose of Varivax. There was no concomitant medication. Since he was administered the vaccine, also reported as "25 Apr 2006", the patient developed a rash below both knees. No medical attention was sought. The outcome was not recovered. No product quality complaint was involved. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Pharyngitis streptococcal, Varicella
Clinical narrative: Information has been received from a consumer and a nurse practitioner concerning the consumer's 6-year-old white daughter with a sulfonamide allergy and allergies, who on 28-AUG-2000 was vaccinated subcutaneously in the right arm with a dose of Varivax (Lot # 634842/1867J). Concomitant therapy included Allegra and sodium fluoride. On 19-APR-2006 (also reported as 02-MAY-2006) the patient experienced breakthrough chickenpox. No medical attention was sought; no laboratory or diagnostic tests were performed. The outcome was reported as recovered, as of 24-APR-2006. No product quality complaint was involved. There were no relevant diagnostic tests or laboratory data. Follow up information indicated that the patient ended up getting strep throat. It was reported that the patient's brother experienced an adverse event following vaccination (WAES# 0604USA03970). No additional information is expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Immune system disorder, Pharyngitis streptococcal, Rash, Scarlet fever, Varicella
Clinical narrative: Information has been received from a consumer concerning her 8-year-old white son with allergies who on 22-FEB-1999 was vaccinated subcutaneously with a dose of Varivax (date unspecified). Concomitant therapy included montelukast sodium (MSD) and sodium fluoride. On 16-APR-2006 the patient experienced breakthrough chickenpox. Unspecified medical attention was sought; no laboratory or diagnostic tests were performed. At the time of the report the patient was recovering. No product quality complaint was involved. Follow-up information received from the mother indicated that the patient's immune system was way below normal. One week post chickenpox, on approximately 23-APR-2006, the patient ended up getting strep throat. However, the mother did not know this at the time because he was not complaining. Three weeks post vaccination, the mother brought the patient back to the physician for a rash. One and one half weeks after that, he developed a severe internal rash all over his body. The patient was diagnosed with scarlet fever. He was treated with 400 mg amoxicillin for 7 days. The mother indicated "so far, he is better." Follow-up information from the nurse practitioner indicated that the patient developed chickenpox on 17-APR-2006 and subsequently recovered. It was reported that the patient's sister developed an adverse reaction following vaccination (WAES# 0604USA03960).
Age: 2.0
Sex: F
Vaccine: DTP, VARCEL
Symptoms: Body temperature, Pruritus, Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old female who on 03 Oct 2002 was vaccinated with a dose of Varivax. Concomitant vaccine administered on the same day included a dose of DPT. On 19 Arp 2006 the patient broke out with about 100 varicella lesions. It was noted that the lesions were sparse and all over the patient's body. The patient did not develop a fever. The patient was given Benadryl for itching. It was reported that the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information is not expected.